Learn more

OMNIGEN RES LLC

Overview
  • Total Patents
    35
  • GoodIP Patent Rank
    69,160
  • Filing trend
    ⇩ 20.0%
About

OMNIGEN RES LLC has a total of 35 patent applications. It decreased the IP activity by 20.0%. Its first patent ever was published in 2005. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets foods and drinks, pharmaceuticals and environmental technology are SHENZHEN HONGRUI BIOLOGICAL SCIENCE & TECH CO LTD, JUVENON INC and FUJIAN AONONG BIOLOGICAL TECH GROUP CO LTD.

Patent filings per year

Chart showing OMNIGEN RES LLCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Forsberg Neil E 16
#2 Puntenney Steven B 14
#3 Puntenney Steven Bruce 9
#4 Calabotta David 9
#5 Chapman James D 9
#6 Mclean Derek 7
#7 Forsberg Neil Elliott 7
#8 Costigan Tim 6
#9 Johnson A Bruce 5
#10 Rowson Angela D 4

Latest patents

Publication Filing date Title
WO2020142305A1 Feed supplements
US2019374622A1 Composition and method for co-administration with a growth promotant
WO2019147799A1 Bacillus combination for administration to animals
CN109688831A Feed addictive comprising allicin
CA2997553A1 A composition and/or combination for aquaculture
AU2011201420A1 Beta-1,3(4)-endoglucanohydrolase, beta-1,3(4) glucan, diatomaceous earth, mineral clay and glucomannan to modulate gastrointestinal genes
NZ591978A Beta-1, 3(4)-endoglucanohydrolase, beta-1,3(4) glucan, diatomaceous earth, mineral clay and glucomannan to modulate gastrointestinal genes
MX2008013619A Augmentation of titer for vaccination in animals.
US2006239992A1 Methods and compositions for the inhibition of growth of infectious Aspergillus fumigatus and other mycotic organisms in the gut of mammalian and avian species
EP1948237A1 USE OF ß-1,3 (4)-ENDOGLUCANOHYDROLASE, ß-1,3 (4) GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION